|
| |
| | | 69161 | | 15.02.2024 | | AbbVie AG | | | | | | | 31.07.2026 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Tepkinly 4 mg/0,8 ml | Injektionslösung | Konzentrat zur Herstellung einer Injektionslösung (Epcoritamabum 4mg / 0.8ml) | L01FX27 | | | 02 | Tepkinly | | (Epcoritamabum 4 mg) | | |
|
|
|
